|  Help  |  About  |  Contact Us

Publication : Susceptibility to early atherosclerosis in male mice is mediated by estrogen receptor alpha.

First Author  Villablanca A Year  2004
Journal  Arterioscler Thromb Vasc Biol Volume  24
Issue  6 Pages  1055-61
PubMed ID  15117737 Mgi Jnum  J:102338
Mgi Id  MGI:3607380 Doi  10.1161/01.ATV.0000130467.65290.d4
Citation  Villablanca A, et al. (2004) Susceptibility to early atherosclerosis in male mice is mediated by estrogen receptor alpha. Arterioscler Thromb Vasc Biol 24(6):1055-61
abstractText  OBJECTIVE: Vascular tissues express 2 types of estrogen receptors (ERs): ERalpha and ERbeta. Their role in early atherosclerosis remains poorly understood, particularly in males. We developed and characterized an atherosclerosis model in ERalpha knockout male mice to investigate directly its role in atheroma. METHODS AND RESULTS: Cholesterol-fed ERalpha knockout and wild-type mice developed early atheroma characterized by fatty streaks and foam cells. ERalpha wild-type mice developed 3.8-fold greater lesion area, more advanced lesions, more extensive lesion distribution, twice the number of lesions, and at a 2.2-fold faster rate than ERalpha knockout mice. Lesion development and atheroma susceptibility in ERalpha wild-type and knockout mice were independent of serum cholesterol, triglycerides, high-density lipoproteins, 17beta-estradiol, and testosterone levels. In contrast, castration eliminated the predilection of ERalpha wild-type mice for atheroma, suggesting that testosterone mediates ERalpha-dependent atheroma formation in males. CONCLUSIONS: This study is the first to report that the ERalpha mediates susceptibility to early atherosclerosis in male mice by a testosterone-dependent pathway, suggesting that local production of estrogen from testosterone in the vessel wall may promote atheroma formation in ERalpha males. Our findings may have implications for selective targeting of ERalpha in atherosclerotic disease.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

3 Bio Entities

Trail: Publication

0 Expression